1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Rtw Investments, Llc Buys Homology Medicines Inc, Relmada Therapeutics Inc, Avadel Pharmaceuticals PLC, Sells Achillion Pharmaceuticals Inc, Quidel Corp, Quotient

New York, NY, based Investment company Rtw Investments, Llc (Current Portfolio) buys Homology Medicines Inc, Relmada Therapeutics Inc, Avadel Pharmaceuticals PLC, Axsome Therapeutics Inc, NanoString Technologies Inc, sells Achillion Pharmaceuticals Inc, Quidel Corp, Quotient, Fluidigm Corp, Silk Road Medical Inc during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Rtw Investments, Llc. As of 2019Q4, Rtw Investments, Llc owns 51 stocks with a total value of $2.5 billion. These are the details of the buys and sells.

For the details of RTW INVESTMENTS, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/rtw+investments%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of RTW INVESTMENTS, LLC
  1. MiMedx Group Inc (MDXG) - 2,702,539 shares, 100.00% of the total portfolio. Shares reduced by 8.82%
  2. Rocket Pharmaceuticals Inc (RCKT) - 16,812,491 shares, 15.70% of the total portfolio. Shares added by 1.36%
  3. Alnylam Pharmaceuticals Inc (ALNY) - 1,637,864 shares, 7.74% of the total portfolio. Shares reduced by 7.34%
  4. PTC Therapeutics Inc (PTCT) - 3,832,480 shares, 7.55% of the total portfolio. Shares added by 4.96%
  5. Dicerna Pharmaceuticals Inc (DRNA) - 5,874,229 shares, 5.31% of the total portfolio. Shares reduced by 5.29%
New Purchase: Relmada Therapeutics Inc (RLMD)

Rtw Investments, Llc initiated holding in Relmada Therapeutics Inc. The purchase prices were between $10.1 and $47.18, with an estimated average price of $28.74. The stock is now traded at around $48.02. The impact to a portfolio due to this purchase was 1.06%. The holding were 664,484 shares as of .

New Purchase: Avadel Pharmaceuticals PLC (AVDL)

Rtw Investments, Llc initiated holding in Avadel Pharmaceuticals PLC. The purchase prices were between $3.34 and $7.7, with an estimated average price of $5.34. The stock is now traded at around $10.06. The impact to a portfolio due to this purchase was 1.05%. The holding were 3,401,434 shares as of .

New Purchase: NanoString Technologies Inc (NSTG)

Rtw Investments, Llc initiated holding in NanoString Technologies Inc. The purchase prices were between $20.34 and $28.15, with an estimated average price of $24.37. The stock is now traded at around $34.45. The impact to a portfolio due to this purchase was 0.66%. The holding were 578,932 shares as of .

New Purchase: WAVE Life Sciences Ltd (WVE)

Rtw Investments, Llc initiated holding in WAVE Life Sciences Ltd. The purchase prices were between $7.99 and $37.6, with an estimated average price of $24.58. The stock is now traded at around $9.25. The impact to a portfolio due to this purchase was 0.56%. The holding were 1,705,474 shares as of .

New Purchase: Agilent Technologies Inc (A)

Rtw Investments, Llc initiated holding in Agilent Technologies Inc. The purchase prices were between $72.49 and $85.45, with an estimated average price of $78.92. The stock is now traded at around $80.46. The impact to a portfolio due to this purchase was 0.52%. The holding were 149,690 shares as of .

New Purchase: Staar Surgical Co (STAA)

Rtw Investments, Llc initiated holding in Staar Surgical Co. The purchase prices were between $24.55 and $38.13, with an estimated average price of $33.24. The stock is now traded at around $31.79. The impact to a portfolio due to this purchase was 0.44%. The holding were 302,211 shares as of .

Added: Homology Medicines Inc (FIXX)

Rtw Investments, Llc added to a holding in Homology Medicines Inc by 77.56%. The purchase prices were between $11.42 and $22.19, with an estimated average price of $15.98. The stock is now traded at around $21.75. The impact to a portfolio due to this purchase was 1.61%. The holding were 4,349,250 shares as of .

Added: Axsome Therapeutics Inc (AXSM)

Rtw Investments, Llc added to a holding in Axsome Therapeutics Inc by 21.36%. The purchase prices were between $17.61 and $106.24, with an estimated average price of $41.69. The stock is now traded at around $88.35. The impact to a portfolio due to this purchase was 0.77%. The holding were 1,026,813 shares as of .

Added: Protagonist Therapeutics Inc (PTGX)

Rtw Investments, Llc added to a holding in Protagonist Therapeutics Inc by 222.71%. The purchase prices were between $4.69 and $13.45, with an estimated average price of $9.84. The stock is now traded at around $8.50. The impact to a portfolio due to this purchase was 0.49%. The holding were 2,459,988 shares as of .

Added: ProQR Therapeutics NV (PRQR)

Rtw Investments, Llc added to a holding in ProQR Therapeutics NV by 29.14%. The purchase prices were between $5.94 and $10.51, with an estimated average price of $7.84. The stock is now traded at around $8.47. The impact to a portfolio due to this purchase was 0.44%. The holding were 4,779,135 shares as of .

Added: Natera Inc (NTRA)

Rtw Investments, Llc added to a holding in Natera Inc by 40.17%. The purchase prices were between $32.7 and $40.4, with an estimated average price of $36.91. The stock is now traded at around $39.43. The impact to a portfolio due to this purchase was 0.16%. The holding were 402,953 shares as of .

Sold Out: Quidel Corp (QDEL)

Rtw Investments, Llc sold out a holding in Quidel Corp. The sale prices were between $55.79 and $75.03, with an estimated average price of $64.75.

Sold Out: Quotient Ltd (QTNT)

Rtw Investments, Llc sold out a holding in Quotient Ltd. The sale prices were between $7.07 and $9.51, with an estimated average price of $8.31.

Sold Out: Fluidigm Corp (FLDM)

Rtw Investments, Llc sold out a holding in Fluidigm Corp. The sale prices were between $2.3 and $5.12, with an estimated average price of $3.49.

Sold Out: Silk Road Medical Inc (SILK)

Rtw Investments, Llc sold out a holding in Silk Road Medical Inc. The sale prices were between $27.97 and $40.38, with an estimated average price of $35.07.

Sold Out: Principia Biopharma Inc (PRNB)

Rtw Investments, Llc sold out a holding in Principia Biopharma Inc. The sale prices were between $26.79 and $60.85, with an estimated average price of $37.8.

Sold Out: Sunesis Pharmaceuticals Inc (SNSS)

Rtw Investments, Llc sold out a holding in Sunesis Pharmaceuticals Inc. The sale prices were between $0.28 and $0.7, with an estimated average price of $0.47.



Here is the complete portfolio of RTW INVESTMENTS, LLC. Also check out:

1. RTW INVESTMENTS, LLC's Undervalued Stocks
2. RTW INVESTMENTS, LLC's Top Growth Companies, and
3. RTW INVESTMENTS, LLC's High Yield stocks
4. Stocks that RTW INVESTMENTS, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)